Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors

NEXT STORY
TRACON Pharmaceuticals Announces Appointment of Lisa Johnson-Pratt, M.D., to its Board of Directors
PREV STORY
OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for Diagnosis of Bacterial Co-Infections in ICU Patients with COVID-19 Pneumonia
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Alpha Mannosidosis Market Overview Shows A Single Company Owning Almost 90% Share As Per The Business Research Company’s Alpha Mannosidosis Global Market Report 2021

author_avatar
NASDAQ Market News

Pernix Therapeutics Announces Reorganization of Senior Management Team

John Sedor Appointed CEO on a Permanent Basis Company Names Pharmaceutical Industry Veteran, Dr. ...

author_avatar
NASDAQ Market News

Ritter Pharmaceuticals Selects Medpace as its Clinical Research Organization for Pivotal Phase 3 Clinical Trial of RP-G28 in Lactose Intolerance

LOS ANGELES, May 03, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) (“Ritter ...

author_avatar
NASDAQ Market News